Zoetis Inc Expands Kalamazoo, Michigan, Manufacturing & Distribution Hub
05/11/2017
Renovations to the 524,000-square foot facility in Kalamazoo will expand production of Simparica (sarolaner) Chewables, the innovative oral flea and tick medication for dogs, which was approved by the U.S. Food and Drug Administration in February 2016. The company expects to begin renovations later this month and to complete the project by early 2019.
Zoetis will install two new production lines and related operations to manufacture oral tablet and chewable medicines for companion animals. The company expects to add up to 45 manufacturing positions in the next three years. The company currently employs approximately 300 colleagues at its manufacturing facilities in Kalamazoo and Portage, including 265 dedicated directly to manufacturing.
“Kalamazoo is home to one of the largest and most important manufacturing sites in Zoetis’ Global Manufacturing and Supply network,” said Matthew Everhart, Vice President, Pharmaceutical and Aseptic Operations, Global Manufacturing and Supply at Zoetis.
“Locating manufacturing here gives us continued access to a highly skilled and diverse workforce which is essential to managing a global animal health company. Our people provide our veterinarian and livestock farmer customers with a reliable supply of high quality medicines for their animals and are an integral part of the community here,” he added.
“We are committed to enhancing our manufacturing operations in Kalamazoo and thank the Michigan Economic Development Corporation, the cities of Kalamazoo and Portage, and Southwest Michigan First for their efforts to attract and help businesses grow in Michigan.”
The Michigan Economic Development Corporation (MEDC) awarded Zoetis a Business Development Program incentive grant.
“Today’s investment announcement by Zoetis will foster a long-term positive impact on western Michigan’s economy and bring new jobs to the area. Numerous public and private partners deserve thanks for helping make this project happen, and we are pleased to support that collaboration,” said MEDC Chief Executive Officer Steve Arwood. “Zoetis’ decision to bolster its production of medicines here demonstrates that our business climate and our state’s world-class talent make Michigan a top destination for biotech companies to locate, expand and grow new jobs.”
Project Announcements
Northland Corporation Expands Greenville, Michigan, Operations
08/29/2024
Swedish Match Expands Daviess County, Kentucky, Operations
08/29/2024
Ardent Mills Expands Commerce City, Colorado, Production Operations
08/29/2024
Paul Mueller Company Expands Springfield, Missouri, Manufacturing Operations
08/29/2024
Nashville Wire Products Expands McEwen, Tennessee, Operations
08/28/2024
Crusoe Energy Systems Plans Tulsa, Oklahoma, Manufacturing Operations
08/27/2024
Most Read
-
19th Annual Area Development Gold and Silver Shovel Awards
Q2 2024
-
What the Latest EPA PFAS Rule Means for Site Due Diligence
Q3 2024
-
Semiconductors’ fragile relationship with water may be tested
Q3 2024
-
2023 Top States Commentary: Top-Ranked States Have What It Takes to Win Mega Projects
Q3 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
Mitigating Site Risks for Industrial Projects
Q3 2024